SCHEMBL6401574

SCHEMBL6401574

O=P(O)(O)c1ccc(O)cc1CCc1ccc(O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.48
ESR2 Q92731 1/20 0.48
LTA4H P09960 1/20 0.46
ALDH1A1 P00352 2/20 0.43
CYP2C19 P33261 2/20 0.43
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
ALOX12 P18054 1/20 0.43
CKS1B P61024 1/20 0.43
SKP2 Q13309 1/20 0.43
HIF1A Q16665 1/20 0.43
HSD17B10 Q99714 1/20 0.43
EGFR P00533 1/20 0.43
LCK P06239 1/20 0.43
TYR P14679 2/20 0.40
CA2 P00918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6399258 0.90 IGF1R (0.46) ESR1ESR2LTA4HALDH1A1TP53
SCHEMBL6394292 0.90 SLC28A3 (0.45) ESR1ESR2LTA4HALDH1A1CYP2C19
SCHEMBL6396942 0.86 ESR1 (0.48) ESR1ESR2LTA4HALDH1A1CYP2C19
SCHEMBL6395987 0.85 DRD2 (0.46) EGFRLCKTYRTAAR1
SCHEMBL7932410 0.78 ESR1 (0.39) ESR1ESR2TP53CYP3A4ALOX15
SCHEMBL6395874 0.77 ESR1 (0.48) ESR1ESR2LTA4HALDH1A1TP53
SCHEMBL6395964 0.77 ALOX15 (0.46) ESR1ESR2LTA4HALDH1A1TP53
SCHEMBL6396042 0.76 MGLL (0.48) TYRTAAR1
SCHEMBL6401888 0.76 CALM1 (0.47) TYRTAAR1
SCHEMBL6401556 0.76 ESR1 (0.44) ESR1ESR2LTA4HALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans PEERCE BRIAN E (US) 2005-08-25 US disclosed
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 ESR1 2885/4885ESR2 2416/4885LTA4H 2051/4885
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 ESR1 2885/4885ESR2 2416/4885LTA4H 2051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.